TGFB1 and cancer: Treatment resistance to intraperitoneal chemotherapy or the progression of peritoneal metastasis can be related to induction of TGF-β1, HIF, MDRT, PARP activation, immunotolerance, persistent EMT of cancer cells or MMT of PMC [136,159,160,161].